rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
1990-9-10
|
pubmed:abstractText |
Monoclonal antibodies were raised against a synthetic NH2-terminal myristoyl tetrapeptide (N-myristoyl-Gly-Ser-Ser-Lys) which is characteristic of an NH2-terminal portion of pp60src, the transforming protein of src-oncogene. The antibody reacted with the albumin conjugated with both the N-myristoyl and N-lauroyl-tetrapeptides, but concentrations at which 50% of the immunoreaction was inhibited were 5 pmol for the N-myristoyl and 830 pmol for N-lauroyl tetrapeptidyl albumin. On the other hand, N-palmitoyl tetrapeptidyl and underivatized albumin, and Gly-Ser-Ser-Lys-Ser-Lys-Pro-Lys octapeptide had no effects. These results suggest a high affinity of the antibody for an N-myristoyl-Gly-Ser-Ser-Lys moiety. src-Oncogene products in Rous sarcoma virus-transformed cells and human colon carcinoma tumor cells were selectively identified as myristoylated pp60src by immunoprecipitation analyses with the antibody.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
170
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
657-64
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:2116793-Adenocarcinoma,
pubmed-meshheading:2116793-Amino Acid Sequence,
pubmed-meshheading:2116793-Antibodies, Monoclonal,
pubmed-meshheading:2116793-Antibody Specificity,
pubmed-meshheading:2116793-Blotting, Western,
pubmed-meshheading:2116793-Colonic Neoplasms,
pubmed-meshheading:2116793-Humans,
pubmed-meshheading:2116793-Molecular Sequence Data,
pubmed-meshheading:2116793-Multiple Myeloma,
pubmed-meshheading:2116793-Myristic Acid,
pubmed-meshheading:2116793-Myristic Acids,
pubmed-meshheading:2116793-Oligopeptides,
pubmed-meshheading:2116793-Oncogene Protein pp60(v-src),
pubmed-meshheading:2116793-Pancreatic Neoplasms,
pubmed-meshheading:2116793-Peptides,
pubmed-meshheading:2116793-Precipitin Tests,
pubmed-meshheading:2116793-Tumor Cells, Cultured
|
pubmed:year |
1990
|
pubmed:articleTitle |
Myristoylated src-oncogene products are potently detected by the monoclonal antibody to the NH2-terminal myristoyl-Gly-Ser-Ser-Lys src-peptide.
|
pubmed:affiliation |
Department of Biochemistry, Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|